Qiagen reports financial growth, credits non-COVID products sales

2021 12 30 00 31 3981 Business Graph Money Stocks 400

Qiagen reported financial growth for the fourth quarter and full 2021 fiscal year, including sales from non-COVID products.

The company reported sales growth of 2% to $582 million for the fourth quarter. It also reported sales growth of 20% to $2.25 billion for the full year.

Qiagen also touted its 22% growth in constant exchange rates in non-COVID product sales, ahead of its 20% target. The company began its 2022 outlook for at least $2.07 billion in net sales, including double-digit constant exchange rate growth in non-COVID products versus 2021.

Page 1 of 138
Next Page